Raymond James Financial Inc Guardant Health, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 63,489 shares of GH stock, worth $3.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,489
Previous 72,364
12.26%
Holding current value
$3.44 Million
Previous $2.21 Million
22.35%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GH
# of Institutions
403Shares Held
123MCall Options Held
1.43MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.1MShares$655 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$609 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$295 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$279 Million0.04% of portfolio
-
Baillie Gifford & CO4.81MShares$261 Million0.2% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.54B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...